RASSF1A-Mediated Suppression of Estrogen Receptor Alpha (ERα)-Driven Breast Cancer Cell Growth Depends on the Hippo-Kinases LATS1 and 2
Around 70% of breast cancers express the estrogen receptor alpha (ERα). This receptor is of central importance for breast cancer development and estrogen-dependent tumor growth. However, the molecular mechanisms that are responsible for the control of ERα expression and function in the context of br...
Main Authors: | Sven Roßwag, Jonathan P. Sleeman, Sonja Thaler |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/11/2868 |
Similar Items
-
Pasteurella multocida activates Rassf1-Hippo-Yap pathway to induce pulmonary epithelial apoptosis
by: Guangfu Zhao, et al.
Published: (2024-03-01) -
The long non-coding RNA ANRASSF1 in the regulation of alternative protein-coding transcripts RASSF1A and RASSF1C in human breast cancer cells: implications to epigenetic therapy
by: Naiade Calanca, et al.
Published: (2019-08-01) -
Prognostic biomarker RASSF1 in head and neck squamous cell carcinoma
by: Yishimei Si, et al.
Published: (2023-10-01) -
IQGAP1 Is a Scaffold of the Core Proteins of the Hippo Pathway and Negatively Regulates the Pro-Apoptotic Signal Mediated by This Pathway
by: Niall P. Quinn, et al.
Published: (2021-02-01) -
Epigenetically inactivated RASSF1A as a tumor biomarker
by: Dora Raos, et al.
Published: (2021-08-01)